Veterans & Addiction
Veterans face elevated rates of substance use disorders driven by combat exposure, military culture and post-discharge transition challenges. The session covers VA treatment models including the addiction-treatment programmes (SUD), military sexual trauma and SUD comorbidity, combat-related PTSD-SUD with concurrent MDMA-assisted therapy trials, opioid prescribing patterns and the VA's stewardship interventions, the transition to civilian care and TRICARE coverage, and the VA-community partnership models including the Mission Act expansion. Discussion addresses suicide-prevention integration in VA addiction services, women veterans' addiction care, traumatic brain injury overlap with SUD, and the elevated overdose risk in the post-deployment year.
- VA SUD treatment programmes
- Military sexual trauma and SUD
- PTSD-SUD with MDMA trials
- VA opioid stewardship
- Mission Act expansion
- Suicide prevention integration
- Women veterans care
- TBI-SUD overlap
Explore the full WCAM 2027 program
- 01Opioid Use Disorder
- 02Alcohol Use Disorder
- 03Stimulants & Polysubstance Use
- 04Behavioral Addictions
- 05Harm Reduction
- 06Medication-Assisted Treatment
- 07Recovery Support Services
- 08Prevention & Early Intervention
- 09Neuroscience of Addiction
- 10Trauma & PTSD-Related Use
- 11Adolescent Addiction
- 12Pregnancy & Addiction
- 13Co-occurring Mental Illness
- 14Tobacco & Nicotine Cessation
- 15Cannabis Use Disorder
- 16Psychedelic-Assisted Therapy
- 17Digital Therapeutics in Addiction
- 18Addiction Policy & Public Health
- 19Methadone & Buprenorphine Programs
- 20Naloxone & Overdose Prevention
- 21Recovery Housing
- 22Peer Support Specialists
- 23Addiction Medicine Training
- 24Stigma & Communication
- 25Drug Policy Reform
- 26International Drug Trends
- 27Older Adults & Addiction
- 29Criminal Justice & Treatment
- 30Family Therapy
- 31Spirituality & Recovery
- 32Genetics of Addiction
- 33Polysubstance Use Trends
- 34Emerging Drugs of Abuse
- 35Workforce Development